期刊文献+

Ⅲ期卵巢上皮性癌手术彻底性对预后的影响 被引量:7

Stage Ⅲ epithelial ovarlan cancer The prognosis of complete tumor excision and residual lesions of less than 2cm.
原文传递
导出
摘要 目的通过分析接受肿瘤细胞减灭术的临床Ⅲ期卵巢上皮性癌患者的手术切净与基本切净的5年存活率,探讨残余肿瘤的大小对其预后的影响。方法自1982年1月至1995年6月,共收治临床Ⅲ期卵巢上皮癌186例,对其进行回顾性研究,并对结果进行统计学处理。结果43例肿瘤切除干净者,其5年存活率为325%;76例肿瘤基本切净者的5年存活率为214%(P<001)。基本切净者,32例术后1年内化疗≥6疗程的5年存活率为252%,44例术后1年内化疗<6疗程的5年存活率为201%。结论肿瘤切净者的5年存活率高于肿瘤基本切净者的5年存活率。术后1年内化疗≥6疗程可提高基本切净者的5年存活率。 Objective To study the 5-year survival rate of complete tumor excision and residual lesions ≤2cm in stage Ⅲ epithelial ovarian cancer,and observe the effect on survival of debulking surgery.Methods 186 cases of stage Ⅲ epithelial ovarian cancer who received treatment in PUMC hospital from Jan,1982 to June,1995 were analyzed retrospectively.Results The 5-year survival rate of 43 cases(36 1%)having complete tumor excision was 32 5%,while for 76 cases (63 9%)having residual lesions≤2cm was 21 4%(P<0 01).Of the cases with residual lesions ≤2cm,the 5-year survival rate of 32 cases having chemotherapy ≥6 cycles in one year was 25.2%,while 44 cases having chemotherapy <6 cycles in one year was 20 1%.Conclusions The 5-ycar survival rate of stage Ⅲ epithelial ovarian cancer having complete tumor excision was higher than that with residual lesions ≤2cm.Of the cases with residual lesions ≤2cm,the patients having chemotherapy ≥6 cycles in one year could raise their 5-year survival rate \ \
出处 《中国实用妇科与产科杂志》 CAS CSCD 北大核心 1999年第2期105-106,共2页 Chinese Journal of Practical Gynecology and Obstetrics
关键词 卵巢肿瘤 切除术 上皮癌 药物疗法 预后 Epithelial ovarian cancer\ Debulking surgery\ Chemotherapy
  • 相关文献

参考文献6

  • 1Blaly P S,Gynecol Oncol,1995年,56卷,164页
  • 2Makar A P,Gynecol Oncol,1995年,56卷,175页
  • 3Can Der Burg M E L,New England J Medicine,1995年,332卷,10期,629页
  • 4Hoskin S W J,Am J Obstet Gynecol,1994年,170期,974页
  • 5Hoskings W J,Gynecol Oncol,1992年,47卷,159页
  • 6NgLW,Gynecol Oncol,1990年,38卷,358页

同被引文献17

  • 1曹泽毅,于莎莎.妇科恶性肿瘤治疗后一年内未控与复发原因的研究——附全国61所医院1753例分析[J].中华妇产科杂志,1996,31(7):417-421. 被引量:21
  • 2[3]Bristow RE, Tomacruz RS, Armstrong DK, et al. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta- analysis. J Clin Oncol, 2002, 20: 1248-1259.
  • 3[5]Eisenkop SM, Friedman RL, Wang HJ, et al. Complete cytoreductive surgery is feasible and msximizes survival in patients with advanced epithelial ovarian cancer: A prospective study. Gynecol Oncol, 1998,69:103 - 108.
  • 4[6]Morice P, Dubernard G, Rey A, et al. Results of interval debulking surgery in advanced stage ovarian cancer. J Am Coll Surg, 2003, 197:955 - 963.
  • 5[7]FanfaniF, Ferrandina G, Corrado G, et al. Impact of interval debulking surgery on clinical outcome in primary unresectable FIGO stage Ⅲ c ovarian cancer patients. Oncology, 2003, 65: 316-322.
  • 6[8]Brun JL, Feyler A, Chene G, et al. Long- term results and prognostic factor in patients with epithelial ovarian cancer. Gynecol Oncol,2000, 78: 21-27.
  • 7来春,段涛,朱美珍.铁林迪妇科手术学.济南:山东科学技术出版社,2003.
  • 8Eisenkop SM,Friedman RI,Wang HT.Complete cytoreductive surgery is feasible and maximizes survival in patiens with advanced ovarian cancer:a prospective study.Genecol Oncol,1998,69(2):103-108.
  • 9NgI W, Rubin, SC. Hosiins WJ. et al. Aggressive chemosurgial debulking in patients with advanced ovarian cancer[ J]. Gynecol Oncol, 1990,38:358.
  • 10Zylberbery B, Ravine JH, Salat-broux J. et al. Chemotherapy by the intravenous and intraperitoneal routes combined in ovarian cancer[J].Gyneco Oncol, 1997,65 : 164.

引证文献7

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部